USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Systemic Autoimmune Diseases to Spur Double-digit Market Growth as Participants Look to Unmet Needs and Game-changing Strategies to Boost Revenues
24-Feb-2016
North America
Market Research
9AB9-00-48-00-00
HC02380-NA-MR_16502
According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as well as localized diseases, such as celiac, IBD, IBS, and Hashimoto's. Systemic diseases dominate the market due to their high prevalence in the United States and also because of the market participation of large diagnostics companies, such as Inova Diagnostics, Siemens Healthcare, Abbott Diagnostics, and Beckman Coulter. The localized disease segment is the fastest-growing, mainly due to celiac, as gluten intolerance in the United States is increasing at an exponential rate.
Scope and Segmentation
Key Predictions: US Autoimmune Disease Diagnostics Market
Current Trends in the Autoimmune Disease Diagnostics Market
Autoimmune Disease Diagnostics Market—Overview
Key Companies to Watch
Ecosystem of the Autoimmune Disease Diagnostics Market
Significance of the Autoimmune Disease Diagnostics Market
Significance of the Autoimmune Disease Diagnostics Market—Prevalence Rates
Competitive Landscape
Key Diseases and Available Solutions in the US Market
Key Diseases and Available Solutions in the US Market (continued)
LDTs—Role in Autoimmune Disease Diagnostics
Segment Lifecycle Analysis by Disease
Overall Market Forecast
Overall Disease Segment Share
Competitive SWOT Analysis by Company
Competitive SWOT Analysis by Company (continued)
Where do the Opportunities Lie in this Market?
Pharma and Diagnostics Business Integration
Autoimmune Diagnostics Companies are Uniting with Pharmaceuticals to Diversify Revenue Channels
Direct-to-Consumer Market: The Risk and The Opportunity
Localized Disease Diagnostics Segment Revenue
Growth Rate by Localized Autoimmune Diseases
Competitive Value Matrix—Localized Disease Diagnostics Segment
Autoimmune Tests—Role in Patient Continuum
Systemic Disease Diagnostics Segment Revenue
Growth Rate by Systemic Autoimmune Diseases
Competitive Value Matrix—Systemic Disease Diagnostics Segment
Autoimmune Tests—Role in Patient Continuum
Key Conclusions and Future Outlook
Legal Disclaimer
Celiac Disease-specific LDT Assays
Chron’s Disease-specific LDT Assays
RA-specific LDT Assays
Lupus-specific LDT Assays
IBD/IBS-specific LDT Assays
Others
Learn More—Next Steps
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
25 Sep 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Diagnostic Solutions, and Implantables
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables.The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based au...
23 Sep 2026 | Global | Technology Research
Programmable Epigenome Editing for Disease Reversal
Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applicati...
21 Sep 2026 | Europe | Market Research
HLTH Europe 2026: Five Key Takeaways and Growth Opportunities
HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...
21 Sep 2026 | Global | Frost Radar
Frost Radar: Smart Nutraceuticals for Brain Health, 2026
This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differen...
18 Sep 2026 | Global | Frost Radar
Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026
Laboratory information management systems (LIMS) have been used in life sciences since laboratories began digitizing sample tracking and data management in the 1970s. Modern LIMS solutions enhance efficiency by automating workflows, improving data accuracy, and enabling seamless integration and offe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | 9AB9-00-48-00-00 |
| Keyword 1 | Autoimmune Disease Diagnostics |
| Keyword 2 | US Autoimmune Disease Diagnostics |
| Keyword 3 | Disease Diagnostics |
| Is Prebook | No |
US Autoimmune Disease Diagnostics Market, Forecast to 2020
$1,500.00
Special Price $1,125.00 save 25 %